Encephalopathy is a broad, non-specific term denoting diffuse dysfunction of the brain parenchyma resulting from an underlying systemic or metabolic cause — including but not limited to hepatic failure, renal failure, hypoxia, hypercapnia, hypo- or hyperglycemia, electrolyte disturbance, sepsis, toxic ingestion, or medication effect — and manifesting clinically as a spectrum from mild confusion and inattention to stupor and coma; it is fundamentally distinguished from encephalitis in that encephalopathy does not primarily involve neuroinflammation, though the two can coexist and are frequently confused in clinical documentation. The underlying pathophysiology varies by subtype: in hepatic encephalopathy, accumulation of ammonia and other gut-derived neurotoxins impairs astrocyte function and glutamatergic/GABAergic neurotransmission (K72.90); in hypoxic-ischemic encephalopathy, neuronal death results from ATP depletion during oxygen deprivation (G93.1); in toxic encephalopathy, exogenous substances (drugs, heavy metals, organic solvents) disrupt neuronal membrane function or neurotransmitter systems (G92.8, G92.9); and in uremic encephalopathy, retained nitrogenous waste products alter the blood-brain barrier and neuronal excitability (N18.x with manifestation code). Encephalopathy may be physiological in the sense that it is fully reversible when the underlying cause is corrected (e.g., hypoglycemic encephalopathy resolving with glucose administration) or may result in permanent structural injury and neurological sequelae (e.g., hypoxic-ischemic encephalopathy following cardiac arrest). The most clinically significant subtypes in inpatient coding are metabolic encephalopathy (G93.41), toxic encephalopathy (G92.8, G92.9), hepatic encephalopathy (K72.90, K72.91), hypoxic-ischemic encephalopathy (G93.1), hypertensive encephalopathy (I67.4), septic encephalopathy (G93.41), and Wernicke encephalopathy (E51.2). Encephalopathy is distinguished from delirium — which is a clinical syndrome of acute fluctuating confusion with attentional disturbance — in that delirium (F05) is the behavioral manifestation often caused by encephalopathy; both codes may be assigned when independently documented, but encephalopathy is the preferred code when a metabolic or toxic cause is identified.
Greek pathos (PAH-thos), from paschein (“to suffer”)
Noun-forming suffix — “disease of,” “disorder of,” “suffering of” — denotes a pathological condition of the named structure without implying a specific mechanism such as inflammation
The word entered English in the 1860s as encephalopathy (noun), formed in modern medical Latin from Greek enkephalos (“brain”) + pathos (“suffering, disease”) — literally “disease of the brain.” The suffix -pathy is one of the most productive in clinical medicine, appearing across all organ systems: neuropathy (nerve disease), cardiomyopathy (heart muscle disease), nephropathy (kidney disease), hepatopathy (liver disease), retinopathy (retinal disease — high frequency in ophthalmology coding), and uropathy (urinary tract disease). The critical semantic distinction between -pathy and -itis is mechanistic: -itis implies inflammation as the primary driver, while -pathy implies dysfunction or disease without specifying the underlying mechanism. The root pathos (“suffering”) also generates pathology, pathogenesis, pathophysiology, and sympathy (literally “suffering together”). The shared encephal- root connects encephalopathy directly to encephalitis and encephalomyelitis — making etymology a reliable guide to the coding distinction: when the suffix is -itis, confirm inflammation; when -pathy, confirm systemic or metabolic cause.
🔀 ALIASES / ALTERNATE TERMS
Encephalopathic(adjective form — clinical collocations include “encephalopathic state,” “encephalopathic presentation,” “encephalopathic patient”; used in critical care, hepatology, and nephrology progress notes)
Altered mental status (AMS)(broad clinical term encompassing confusion, disorientation, lethargy, and obtundation; when the clinician documents AMS and identifies a metabolic cause, code the encephalopathy — do not code AMS separately; R41.3 if no etiology established)
Metabolic encephalopathy(encephalopathy caused by any metabolic derangement — electrolyte imbalance, hypoglycemia, uremia, hepatic failure, CO2 retention; G93.41; the most commonly assigned encephalopathy code in inpatient settings)
Hepatic encephalopathy(brain dysfunction caused by liver failure with accumulation of ammonia and neurotoxins; K72.90 without coma, K72.91 with coma; sequences as principal or additional diagnosis depending on admission reason)
Hypoxic-ischemic encephalopathy (HIE)(brain injury from combined oxygen and blood flow deprivation; G93.1; post-cardiac arrest encephalopathy is the most common adult form; neonatal HIE coded separately to P91.60-P91.63)
Toxic encephalopathy(brain dysfunction caused by exogenous toxins, drugs, heavy metals, or chemical agents; G92.8 other toxic, G92.9 unspecified toxic; requires T-code for the toxic substance as additional diagnosis)
Wernicke encephalopathy(thiamine-deficiency encephalopathy with classic triad of confusion, ophthalmoplegia, and ataxia; E51.2; high-risk populations include alcoholism, malnutrition, prolonged IV nutrition without thiamine supplementation)
Hypertensive encephalopathy(acute brain dysfunction due to severe hypertension exceeding autoregulatory capacity; I67.4; associated with posterior reversible encephalopathy syndrome, PRES)
Septic encephalopathy(brain dysfunction in the setting of systemic sepsis, without direct CNS infection; coded to G93.41 metabolic encephalopathy plus sepsis code; one of the most common causes of ICU-level altered mental status)
Uremic encephalopathy(brain dysfunction caused by accumulation of uremic toxins in renal failure; coded to G93.41 plus N18.x for the CKD stage; distinguished from dialysis disequilibrium syndrome)
Posterior reversible encephalopathy syndrome (PRES)(vasogenic edema of posterior cerebral regions associated with hypertension, eclampsia, immunosuppressants, or sepsis; I67.83; reversible with blood pressure control)
Chronic traumatic encephalopathy (CTE)(progressive neurodegenerative encephalopathy from repetitive head trauma; G31.85; distinct from acute traumatic brain injury)
🔗 RELATED TERMS
encephalitis — the most clinically critical distinction: encephalitis implies primary neuroinflammation (infectious or autoimmune), while encephalopathy implies brain dysfunction from a systemic or exogenous cause without primary inflammation; the two are frequently conflated in physician documentation — query when CSF, MRI, or clinical pattern suggests inflammation in a patient coded only to encephalopathy
Delirium — the acute neurobehavioral syndrome (fluctuating confusion, inattention, altered arousal) that is the clinical expression of encephalopathy; F05 for delirium not superimposed on dementia; both codes may be assigned when clearly documented; encephalopathy is the preferred code when an identified metabolic/toxic cause is documented
Coma — the most severe point on the encephalopathy spectrum; coded separately with R40.20-R40.24 Glasgow Coma Scale codes as required by guidelines; hepatic coma specifically captured by K72.91 (hepatic failure with coma)
Dementia — a chronic, progressive cognitive decline syndrome distinct from acute/subacute encephalopathy; encephalopathy superimposed on dementia is a common inpatient scenario and both should be coded; delirium superimposed on dementia codes to F05
Asterixis — a characteristic motor finding (flapping tremor of outstretched hands) highly associated with hepatic, uremic, and CO2-retention encephalopathy; coded to R25.1 (tremor, unspecified) or R25.8 when documented; a documentation trigger to query underlying encephalopathy type
Ammonia — the primary neurotoxin in hepatic encephalopathy; elevated serum ammonia (E72.21 hyperammonemia) drives astrocyte swelling and cerebral edema in acute liver failure; ammonia levels guide clinical management
Blood-brain barrier — the selective endothelial barrier separating systemic circulation from CNS parenchyma; disruption of the BBB is a common pathway in both toxic and septic encephalopathy, allowing neurotoxic substances access to CNS tissue
Glasgow Coma Scale (GCS) — the standardized neurological assessment tool for level of consciousness; ICD-10-CM requires GCS score coding (R40.21x-R40.23x) for most comatose patients and for trauma patients; relevant to encephalopathy severity documentation
Posterior reversible encephalopathy syndrome (PRES) — a neuroimaging-defined syndrome of vasogenic cerebral edema in posterior regions; I67.83; closely associated with hypertensive encephalopathy, eclampsia, and calcineurin inhibitor toxicity; MRI is diagnostic
Thiamine (Vitamin B1) — the essential cofactor whose deficiency causes Wernicke encephalopathy (E51.2); deficiency coded to E51.9 thiamine deficiency unspecified or E51.11 dry beriberi, E51.12 wet beriberi; IV thiamine administration is urgent and life-saving
Hepatic failure — the primary driver of hepatic encephalopathy; K72.00 acute hepatic failure without coma, K72.01 with coma; distinguish acute (K72.0x), subacute (K72.0x), and chronic (K72.1x) forms — each has a with/without coma variant
EEG (Electroencephalogram) — key diagnostic tool for encephalopathy; triphasic waves are classic for metabolic/hepatic encephalopathy; continuous EEG monitoring detects nonconvulsive status epilepticus complicating encephalopathy; CPT 95812, 95819, 95950
⚠️ Coding Note:Encephalopathy is one of the highest-impact undercoding opportunities in inpatient profee — G93.41 metabolic encephalopathy and G93.40 unspecified encephalopathy are MCC and CC respectively under MS-DRG logic, meaning their presence significantly affects DRG weight and reimbursement, yet they are routinely undercoded when physicians document only “altered mental status” (R41.3) or “confusion” without a causal qualifier; documentation triggers that should prompt a query include “AMS,” “confusion,” “not at baseline,” “somnolent,” “obtunded,” or “not following commands” in the context of any identified metabolic derangement (sepsis, liver failure, renal failure, hypoxia, hyponatremia, hyperammonemia, or drug toxicity). For hepatic encephalopathy, always verify whether the admission qualifies as hepatic failure with or without coma (K72.90 vs. K72.91) — the with-coma distinction is an MCC and also changes sequencing, as hepatic failure codes to the K72.x category, which includes encephalopathy as a manifestation, making a separate G93.41 potentially redundant per Tabular instruction; query the clinician for explicit documentation of “hepatic encephalopathy” to support the K72.x code with its built-in severity capture. Toxic encephalopathy (G92.8, G92.9) always requires a companion T-code for the causative substance per ICD-10-CM guidelines — do not assign G92.x without the T-code identifying the drug or toxic agent, and apply the correct T-code 7th character for encounter type (A initial, D subsequent, S sequela). Septic encephalopathy is a high-frequency ICU coding scenario — it is correctly coded to G93.41 plus the sepsis code (A41.x), not to encephalitis; if a provider documents “septic encephalopathy,” it can be assigned to G93.41 without a query since the term is indexed there, but confirm no CSF or MRI evidence of true encephalitis before finalizing.
Crystal's Coder Hub